The October 2023 workshop provided a forum for Australia’s leading cancer researchers, CCTGs, and the GCCTI Scientific Steering Group and Project Team to focus on topics and generate ideas for future research. This workshop sessions included:
- Proposal updates from previous workshops
- Grants updates from funding bodies MRFF, NHMRC and Cancer Australia
- Masterclass for cancer clinical trialists
- Trials and concepts for discussion
- Updates from selected CCTGs and groups
- Androgen signalling modulation across the cancer spectrum
Workshop Downloads
Presentations
- Overview of GCCTI and working with GCCTI (Martin Stockler)
- Proposal updates from previous workshops
- Grants update: what’s helpful for grant-writers
- MRFF – Cancer Clinical Trials Grants Opportunities (Ruth Griffiths)
- NHMRC – Clinical Trials and Cohort Studies (David Phillips)
- Cancer Australia – Priority-driven Collaborative Cancer Research Scheme (Jacqui Real)
- Genomics Framework update – Development of a National Framework for Genomics in cancer controll (Sarah McNeill)
- Masterclass for cancer clinical trialists
- Trials and concepts for discussion
- Creating a pathway for advanced thyroid cancer management (Anthony Glover)
- Preoperative hypo-fractionated radiosurgery for brain metastases – feasibility and efficacy (Neda Hagighi)
- Updates from selected CCTGs and groups
- Androgen signalling modulation across the cancer spectrum
- Introduction to androgen receptor signalling targeting in prostate cancer (Andrew Redfern)
- Androgen receptor as a target across the cancer spectrum (Andrew Redfern)
- Androgen receptor targeting in breast cancer (Wayne Tilley)
- Parallels to support care between breast and prostate cancer (Felicia Roncolato and Belinda Kiely)
- Extending androgen receptor modulation to bladder cancer and beyond (Andrew Redfern)
Workshop Report
The workshop report includes a summary of presentations and discussion from the day, including the workshop evaluation. It can be accessed from the link below.